» Articles » PMID: 17767505

Impairment of Hippocampal Gamma-frequency Oscillations in Vitro in Mice Overexpressing Human Amyloid Precursor Protein (APP)

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2007 Sep 5
PMID 17767505
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is associated with a dramatic decline in cognitive performance including hippocampal-dependent memory. We have investigated one feature of hippocampal activity related to memory, the gamma (30-80 Hz)-frequency rhythm. Hippocampal slices from mice overexpressing the human amyloid precursor protein (APP)(SWE) mutation (TAS10) were compared at 8 and 16 months of age with wild-type littermates. In slices obtained from TAS10 mice aged 8 months the gamma-frequency activity evoked with bath application of 200 nm kainate was significantly (P < 0.05; n = 8 slices, five animals) impaired (area power, 5956 +/- 2487 microV(2)) compared to slices from wild-type animals (area power, 18 256 +/- 7880 microV(2)). At 16 months of age there was no longer a significant difference (P > 0.05; n = 11 slices from five animals) between slices from TAS10 and wild-type control mice as the wild-type mice now exhibited a marked age-dependent reduction in gamma-frequency activity (TAS10 area power, 5751 +/- 1573 microV(2); wild-type area power = 5379 +/- 1454 microV(2)). Although no dense-core plaques were evident at 8 months there was detectable amyloid labelling in the TAS10 mice which might account for the deficits in gamma activity observed at this age. Dense plaques were clearly evident in the TAS10, but not wild-type, mice at 16 months of age but no further reductions in gamma-frequency activity were seen in the TAS10 mice. These data suggest that deficits in network function in Alzheimer's disease occur early and are not directly correlated to amyloid load.

Citing Articles

Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ.

Kiourtis C, Terradas-Terradas M, Gee L, May S, Georgakopoulou A, Collins A Nat Cell Biol. 2024; 26(12):2075-2083.

PMID: 39537753 PMC: 11628396. DOI: 10.1038/s41556-024-01543-3.


A novel mouse model of mitochondrial disease exhibits juvenile-onset severe neurological impairment due to parvalbumin cell mitochondrial dysfunction.

Olkhova E, Bradshaw C, Blain A, Alvim D, Turnbull D, LeBeau F Commun Biol. 2023; 6(1):1078.

PMID: 37872380 PMC: 10593770. DOI: 10.1038/s42003-023-05238-7.


Early classification of Alzheimer's disease phenotype based on hippocampal electrophysiology in the TgF344-AD rat model.

Moradi F, van den Berg M, Mirjebreili M, Kosten L, Verhoye M, Amiri M iScience. 2023; 26(8):107454.

PMID: 37599835 PMC: 10432721. DOI: 10.1016/j.isci.2023.107454.


Fast-spiking parvalbumin-positive interneurons in brain physiology and Alzheimer's disease.

Hijazi S, Smit A, Van Kesteren R Mol Psychiatry. 2023; 28(12):4954-4967.

PMID: 37419975 PMC: 11041664. DOI: 10.1038/s41380-023-02168-y.


Mechanisms and Functions of Activity-Regulated Cytoskeleton-Associated Protein in Synaptic Plasticity.

Chen Y, Wang X, Xiao B, Luo Z, Long H Mol Neurobiol. 2023; 60(10):5738-5754.

PMID: 37338805 DOI: 10.1007/s12035-023-03442-4.